Serina Therapeutics, Inc. Restructuring Charges
Serina Therapeutics, Inc. (SER) reported Restructuring Charges of $195.00 thousand for the 1-month period ending 2020-04-30, per its 10-K filed 2022-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2022-03-29
- 2020-04-30: Restructuring Charges 1 month $195.00K; Restructuring Charges 1 month as first filed $194.80K.
| Period end | Restructuring Charges 1 month | Restructuring Charges 1 month as first filed |
|---|---|---|
| 2020-04-30 | $195.00K 10-K · filed 2022-03-29 | $194.80K 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |